Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis-Reference-Cited by-同舟云学术

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis

Published:2011-01-18 Issue:8 Volume:108 Page:1279-1283
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Josephs Debra,Hutson Thomas E.,Cowey Charles L.,Pickering Lisa M.,Larkin James M.,Gore Martin E.,Van Hemelrijck Mieke,McDermott David F.,Powles Thomas,Chowdhury Paramit,Karapetis Chris,Harper Peter G.,Choueiri Toni K.,Chowdhury Simon

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09990.x/fullpdf

Reference19 articles.

1. Global Cancer Statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Sunitinib versus intereron alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Pfizer Laboratories Sutent® Sunitinib Maleate Capsules 2006 http://www.pfizer.com/files/products/uspi_sutent.pdf

4. Goddard J Harris K Turner N Chronic Kidney Disease eGuide 2009 http://www.renal.org/whatwedo/InformationResources/CKDeGUID.aspx

5. Safety and efficacy analysis of sunitinib, bevacizumab, and m-TOR inhibitors in metastatic renal cell cancer patients with renal insufficiency;Gupta;J Clin Oncol,2009

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment;Urologic Oncology: Seminars and Original Investigations;2023-11

2. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03

3. Approach to Special Populations with Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

4. Renal Cell Cancer and Chronic Kidney Disease;Advances in Chronic Kidney Disease;2021-09

5. Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function;Cancer Chemotherapy and Pharmacology;2021-03-25